Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Conditions
Brief summary
This study is conducted in Asia. The aim of this observational study is to describe the diabetes management, control status and complication profile in a diabetic population of Philippines.
Interventions
OTHERNo treatment given
Subject will only fill out a questionaire when entering the observational study.
Sponsors
Novo Nordisk A/S
Study design
Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diabetic patients registered in the particular centre for more than 12 months * Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit * Patients willing to sign informed consent form
Exclusion criteria
* Repetition of any patient as patients should not be included twice for any reason * Unwilling to participate or unable to comply with protocol requirements
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients on Insulin therapy | at baseline visit/study start |
| Mean duration of treatment of type 2 DM | at baseline visit/study start |
| Mean age of onset of type 1 diabetes mellitus | at baseline visit/study start |
| Mean age of onset of type 2 diabetes mellitus | at baseline visit/study start |
| Percentage of patients on OAD therapy | at baseline visit/study start |
| Mean duration of diabetes in type 1 and type 2 patients respectively | at baseline visit/study start |
| Mean FPG of diabetic patients | at baseline visit/study start |
| Mean PPG of diabetic patients | at baseline visit/study start |
| Mean HbA1c of diabetic patients | at baseline visit/study start |
| Percentage of diabetic patients with HbA1c target below 7.0% | at baseline visit/study start |
| Percentage of diabetic patients with HbA1c target below 6.5% | at baseline visit/study start |
| Percentage of diabetic patients having dyslipidemia and hypertension | at baseline visit/study start |
| Percentage of diabetic patients having cardiovascular complications | at baseline visit/study start |
| Percentage of diabetic patients having peripheral vascular disease | at baseline visit/study start |
| Percentage of diabetic patients having diabetic nephropathy | at baseline visit/study start |
| Percentage of diabetic patients having diabetic eye complications | at baseline visit/study start |
Secondary
| Measure | Time frame |
|---|---|
| Duration of diabetes associated with highest number of diabetic complications | at baseline visit/study start |
| Patients' perception will be analysed through Patient questionnaire measuring: Psychological well-being, Quality of life, Patients' compliant to treatment | at baseline visit/study start |
| Physician perception of diabetes and its management will be analysed through Physician questionnaire measuring awareness about:o HbA1c test and its goal,Anti-diabetic treatment,Barriers towards optimum diabetes control | at baseline visit/study start |
| Minimum duration of diabetes associated with 10% incidence of diabetic complications (CVD, nephropathy and retinopathy) | at baseline visit/study start |
Countries
Philippines
Outcome results
None listed